Mind Medicine Inc [MNMD] stock is trading at $7.48, up 1.08%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MNMD shares have gain 4.62% over the last week, with a monthly amount drifted -3.61%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, ROTH MKM started tracking the stock with Buy rating on July 24, 2024, and set its price target to $36. On May 29, 2024, Robert W. Baird initiated with a Outperform rating and assigned a price target of $27 on the stock. Leerink Partners started tracking the stock assigning a Outperform rating and suggested a price target of $20 on April 15, 2024. Canaccord Genuity initiated its recommendation with a Buy and recommended $9 as its price target on December 05, 2023. In a note dated November 16, 2022, RBC Capital Mkts initiated an Outperform rating and provided a target price of $5 on this stock.
Mind Medicine Inc [MNMD] stock has fluctuated between $3.27 and $12.22 over the past year. Currently, Wall Street analysts expect the stock to reach $14 within the next 12 months. Mind Medicine Inc [NASDAQ: MNMD] shares were valued at $7.48 at the most recent close of the market. An investor can expect a potential return of 87.17% based on the average MNMD price forecast.
Analyzing the MNMD fundamentals
Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at -19.36%, Pretax Profit Margin comes in at -20.22%, and Net Profit Margin reading is -20.22%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -0.53 and Total Capital is -0.33. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.33 points at the first support level, and at 7.18 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.60, and for the 2nd resistance point, it is at 7.72.
Ratios To Look Out For
For context, Mind Medicine Inc’s Current Ratio is 9.00. Further, the Quick Ratio stands at 9.00, while the Cash Ratio is 8.88.
Transactions by insiders
Recent insider trading involved GRYSKA DAVID W, Director, that happened on Dec 05 ’24 when 2500.0 shares were purchased. Officer, Sullivan, Mark completed a deal on Sep 25 ’24 to buy 4430.0 shares. Meanwhile, Chief Accounting Officer Liao Carrie sold 2352.0 shares on Sep 25 ’24.
